DSpace Repository

Substandard medicines in resource-poor settings: A problem that can no longer be ignored

Show simple item record

dc.contributor Médecins Sans Frontières, Geneva, Switzerland; AEDES Foundation, Brussels, Belgium
dc.creator Caudron, J M
dc.creator Ford, N
dc.creator Henkens, M
dc.creator Macé, C
dc.creator Kiddle-Monroe, R
dc.creator Pinel, J
dc.date 2008-07-08
dc.date.accessioned 2017-01-31T07:11:47Z
dc.date.available 2017-01-31T07:11:47Z
dc.identifier Trop Med Int Health 2008;13(8):1062–72
dc.identifier 1365-3156
dc.identifier 18631318
dc.identifier 10.1111/j.1365-3156.2008.02106.x
dc.identifier http://hdl.handle.net/10144/37334
dc.identifier http://fieldresearch.msf.org/msf/handle/10144/37334
dc.identifier Tropical Medicine & International Health
dc.identifier.uri http://dspace.mediu.edu.my:8181/xmlui/handle/10144/37334
dc.description The circulation of substandard medicines in the developing world is a serious clinical and public health concern. Problems include under or over concentration of ingredients, contamination, poor quality ingredients, poor stability and inadequate packaging. There are multiple causes. Drugs manufactured for export are not regulated to the same standard as those for domestic use, while regulatory agencies in the less-developed world are poorly equipped to assess and address the problem. A number of recent initiatives have been established to address the problem, most notably the WHO pre-qualification programme. However, much more action is required. Donors should encourage their partners to include more explicit quality requirements in their tender mechanisms, while purchasers should insist that producers and distributors supply drugs that comply with international quality standards. Governments in rich countries should not tolerate the export of substandard pharmaceutical products to poor countries, while developing country governments should improve their ability to detect substandard medicines.
dc.language en
dc.relation http://www3.interscience.wiley.com/journal/120747094/abstract
dc.rights Archived on this site with the kind permission of Wiley-Blackwell, [url]http://www.blackwell-synergy.com/loi/tmi[/url]
dc.title Substandard medicines in resource-poor settings: A problem that can no longer be ignored
dc.type Article

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account